Your browser doesn't support javascript.
loading
The efficacy and reliability of sequential adjuvant anthracycline-based chemotherapy and weekly paclitaxel regimen in human epidermal growth factor receptor 2 negative breast cancer: A retrospective analysis of a multicentre study.
J BUON ; 24(3): 1081-1086, 2019.
Article in En | MEDLINE | ID: mdl-31424664
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Chemotherapy, Adjuvant / Paclitaxel / Receptor, ErbB-2 / Anthracyclines Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: J BUON Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: Turkey
Search on Google
Collection: 01-internacional Database: MEDLINE Main subject: Breast Neoplasms / Chemotherapy, Adjuvant / Paclitaxel / Receptor, ErbB-2 / Anthracyclines Type of study: Observational_studies / Prognostic_studies Limits: Adult / Aged / Aged80 / Female / Humans / Middle aged Language: En Journal: J BUON Journal subject: NEOPLASIAS Year: 2019 Type: Article Affiliation country: Turkey